About Jimena Vicencio

Articles by Jimena Vicencio, MD

The Impact of Income and Location in Myeloma Patients’ Outcomes
Jun 23, 2025
Accessing Specialized Care Centers Can Help Reduce Health Disparities for People with Multiple Myeloma
Jun 19, 2025
Dual Antibody Therapy for Extramedullary Myeloma
Jun 17, 2025
Adding Polatuzumab Vedotin to R-GemOx Shows Longer Survival in Difficult-to-Treat DLBCL
Jun 16, 2025
New Guidelines Define High-Risk Myeloma with Genetics in Mind
Jun 13, 2025
HealthTree Research: Helping Myeloma Patients Match Clinical Trials With AI
Jun 13, 2025
Optimizing Care for Frailty in Myeloma Patients
Jun 12, 2025
ASCO 2025: Rusfertide for Polycythemia Vera
Jun 10, 2025
Building Community is a Pillar of Self-Care
Jun 09, 2025
A New Way to Administer Isatuximab (Sarclisa) That Reduces Side Effects
Jun 05, 2025
A New COVID-19 Protection Option Is Now Available for People with B-cell Lymphoma
Jun 03, 2025
Breaking the Stigma: Debunking Mental Health Myths
May 30, 2025
The Emotional Toll of B-Cell Lymphoma
May 26, 2025
Could a Taurine Supplement Fuel Leukemia Cell Growth?
May 23, 2025
$Two-Year Study Update: Glofitamab (Columvi) with GemOx for Relapsed/Refractory DLBCL image$

Two-Year Study Update: Glofitamab (Columvi) with GemOx for Relapsed/Refractory DLBCL
May 23, 2025
How Can Antidepressants Aid Cancer Care?
May 23, 2025
How MDS Affects Life and Finances: The Role of Treatment, Sex, and Race
May 22, 2025
Closing the Gaps in Multiple Myeloma Care for African Americans
May 21, 2025
HealthTree Research At The COMy Conference: How Early Are Myeloma Patients Diagnosed?
May 20, 2025
New Treatment for Reducing the Risk of Graft Versus Host Disease After Allogeneic Stem Cell Transplant
May 20, 2025
$FDA Grants Fast Track for ISB 2001: A Trispecific Antibody for Relapsed/Refractory Multiple Myeloma image$

FDA Grants Fast Track for ISB 2001: A Trispecific Antibody for Relapsed/Refractory Multiple Myeloma
May 16, 2025
Could Teclistamab Help Newly Diagnosed Myeloma Patients Live Longer After Transplant?
May 15, 2025
Latest Updates of Revumenib for Acute Leukemia
May 12, 2025
When Is the Best Time to Start Erythropoietin-Stimulating Agents for MDS?
May 12, 2025